KKR buys Medicover’s India hospitals businessGlobal investment firm KKR has acquired Medicover India's hospital business. Sources said the the transaction values the hospital chain at ...
06 Aug, 2026, 12.03 PM IST
KKR to acquire Medicover India in $1.5 billion dealThe transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth ...
06 Aug, 2026, 06.00 AM IST
Manipal Health Enterprises shares list at 11% premium over IPO price on BSE, NSEManipal Health Enterprises shares debuted on Wednesday with an 11% premium. The IPO garnered strong demand, especially from institutional i...
05 Aug, 2026, 10.57 AM IST
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
05 Aug, 2026, 10.03 AM IST
ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
04 Aug, 2026, 04.20 PM IST
ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyFrom AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...
04 Aug, 2026, 03.55 PM IST
Manipal Health Enterprises IPO listing tomorrow: Here’s what GMP indicates ahead of market debutManipal Health Enterprises is set to list its Rs 9,275.22 crore mainboard IPO on the BSE and NSE on August 5. With grey market trends indic...
04 Aug, 2026, 10.03 AM IST
Manipal Health Enterprises IPO allotment likely today: How to check status, GMP, listing date, key detailsOnce the allotment process is completed, applicants can check whether they have been allotted shares through the registrar, KFin Technologi...
03 Aug, 2026, 07.40 AM IST
MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...
03 Aug, 2026, 06.30 AM IST
Manipal Health IPO booked nearly 5 times on strong QIB push. Check GMP & other key detailsManipal Health Enterprises' Rs 9,275-crore IPO closed with strong demand, subscribed 4.92 times overall. Institutional investors led the su...
31 Jul, 2026, 08.38 PM IST
Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest,...
30 Jul, 2026, 09.33 AM IST
Can Manipal Health IPO deliver long-term growth for high risk investors?Manipal Health Enterprises plans to raise ₹8,000 crore through a fresh issue for debt repayment and expansion. The company's revenue grew s...
30 Jul, 2026, 05.38 AM IST
BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
28 Jul, 2026, 11.49 PM IST
Andhra Pradesh teams up with AstraZeneca for next-gen cancer care modelAndhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial int...
28 Jul, 2026, 07.30 PM IST
Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
28 Jul, 2026, 01.42 PM IST
India contributes one-third of global oral cancer burden; early detection key to survival, says oral cancer expertIndia contends with a pressing oral cancer crisis, with thousands of new diagnoses and deaths emerging annually. The predominant factor beh...
23 Jul, 2026, 05.22 PM IST
Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...
22 Jul, 2026, 12.54 AM IST